ResMed

ResMed RSMDF Stock

$24.07   0.000000%
Add to favorites
Market Cap
$33.86B
LOW - HIGH [24H]
$24.03 - $24.07
VOLUME [24H]
$400.00
P/E Ratio
21.88
Earnings per share
$1.10
ISIN
AU000000RMD6
Price   Prediction

ResMed Price Chart

Sorry, that's all we've gotfor now...

ResMed (RSMDF) stock price today is 24.07 USD on OTC Markets OTCPK (0% on the day). Updated .

ResMed RSMDF Financial and Trading Overview

ResMed stock price 24.07 USD
Previous Close 24.07 USD
Open 24.03 USD
Bid 23.27 USD x 20000
Ask 24.45 USD x 10000
Day's Range 24.03 - 24.07 USD
52 Week Range 11.85 - 28.25 USD
Volume 400 USD
Avg. Volume 34 USD
Market Cap 33.86B USD
Beta (5Y Monthly) 0.763
PE Ratio (TTM) 21.881817
EPS (TTM) 1.1 USD
Forward Dividend & Yield 0.26 (1.09%)
Ex-Dividend Date November 12, 2026
1y Target Est N/A

RSMDF Valuation Measures

Enterprise Value 13.14B USD
Trailing P/E 21.881817
Forward P/E 58.707317
PEG Ratio (5 yr expected) 1.29
Price/Sales (ttm) 5.905822
Price/Book (mrq) 2.2766612
Enterprise Value/Revenue 2.293
Enterprise Value/EBITDA 6.18

Trading Information

ResMed Stock Price History

Beta (5Y Monthly) 0.763
52-Week Change 0.29%
S&P500 52-Week Change 12.07%
52 Week High 28.25 USD
52 Week Low 11.85 USD
50-Day Moving Average 22.81 USD
200-Day Moving Average 21.51 USD

RSMDF Share Statistics

Avg. Volume (3 month) 34 USD
Avg. Daily Volume (10-Days) 50 USD
Shares Outstanding 1.41B
Float 559.18M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 10.11%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 2.46
Trailing Annual Dividend Yield 10.22%
5 Year Average Dividend Yield 90.00%
Payout Ratio 0.22399999
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2026
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End June 30, 2027

Profitability

Profit Margin 27.79%
Operating Margin (ttm) 34.02%
Gross Margin 61.77%
EBITDA Margin 37.09%

Management Effectiveness

Return on Assets (ttm) 14.75%
Return on Equity (ttm) 26.40%

Income Statement

Revenue (ttm) 5.73B USD
Revenue Per Share (ttm) 9.9 USD
Quarterly Revenue Growth (yoy) 5.89%
Gross Profit (ttm) 3.54B USD
EBITDA 2.13B USD
Net Income Avi to Common (ttm) 1.59B USD
Diluted EPS (ttm) 1.1
Quarterly Earnings Growth (yoy) 20.00%

Balance Sheet

Total Cash (mrq) 1.01B USD
Total Cash Per Share (mrq) 1.8 USD
Total Debt (mrq) 610.58M USD
Total Debt/Equity (mrq) 10.27 USD
Current Ratio (mrq) 2.65
Book Value Per Share (mrq) 10.5725

Cash Flow Statement

Operating Cash Flow (ttm) 1.77B USD
Levered Free Cash Flow (ttm) 1.3B USD

Profile of ResMed

Country United States
State CA
City San Diego
Address 9001 Spectrum Center Boulevard
ZIP 92123
Phone 858-836-5000
Website https://www.resmed.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 11370

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Q&A For ResMed Stock

What is a current RSMDF stock price?

ResMed RSMDF stock price today per share is 24.07 USD.

How to purchase ResMed stock?

You can buy RSMDF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ResMed?

The stock symbol or ticker of ResMed is RSMDF.

Which industry does the ResMed company belong to?

The ResMed industry is Medical Instruments & Supplies.

How many shares does ResMed have in circulation?

The max supply of ResMed shares is 1.41B.

What is ResMed Price to Earnings Ratio (PE Ratio)?

ResMed PE Ratio is 21.88181700 now.

What was ResMed earnings per share over the trailing 12 months (TTM)?

ResMed EPS is 1.1 USD over the trailing 12 months.

Which sector does the ResMed company belong to?

The ResMed sector is Healthcare.

$2.2T
Total marketcap
$70.98B
Total volume
BTC 58.28%   •   ETH 9.92%
Dominance
Select currency